Receptors, Adiponectin

Publication Title: 
Nature

Adiponectin secreted from adipocytes binds to adiponectin receptors AdipoR1 and AdipoR2, and exerts antidiabetic effects via activation of AMPK and PPAR-? pathways, respectively. Levels of adiponectin in plasma are reduced in obesity, which causes insulin resistance and type 2 diabetes. Thus, orally active small molecules that bind to and activate AdipoR1 and AdipoR2 could ameliorate obesity-related diseases such as type 2 diabetes. Here we report the identification of orally active synthetic small-molecule AdipoR agonists.

Author(s): 
Okada-Iwabu, Miki
Yamauchi, Toshimasa
Iwabu, Masato
Honma, Teruki
Hamagami, Ken-ichi
Matsuda, Koichi
Yamaguchi, Mamiko
Tanabe, Hiroaki
Kimura-Someya, Tomomi
Shirouzu, Mikako
Ogata, Hitomi
Tokuyama, Kumpei
Ueki, Kohjiro
Nagano, Tetsuo
Tanaka, Akiko
Yokoyama, Shigeyuki
Kadowaki, Takashi
Publication Title: 
Zhong Xi Yi Jie He Xue Bao = Journal of Chinese Integrative Medicine

OBJECTIVE: To explore the effects of Qushi Huayu Decoction (QSHYD), a compound traditional Chinese herbal medicine, in prevention and treatment of non-alcoholic fatty liver disease (NAFLD) in rats. METHODS: Forty Wistar male rats were used to establish the NAFLD model by subcutaneous injection of carbon tetrachloride (CCl(4)) for 4 weeks (twice weekly) along with high-fat and low-protein diet for 2 weeks. After two-week administration, the rats were randomly divided into four groups: untreated group, high-dose QSHYD group, medium-dose QSHYD group and low-dose QSHYD group.

Author(s): 
Li, Hong-Shan
Feng, Qin
Xu, Li-Li
Chen, Shao-Dong
Li, Xue-mei
Hu, Yi-Yang
Subscribe to RSS - Receptors, Adiponectin